Pembrolizumab in the preoperative setting of triple-negative breast cancer: safety and efficacy
Author:
Affiliation:
1. Oncology Center, Hospital Sírio-Libanês, Brazília, Brazil
2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Funder
no funding
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2020.1823224
Reference34 articles.
1. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
2. The future of immune checkpoint therapy
3. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
4. Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
5. The genomic landscape of breast cancer and its interaction with host immunity
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication;Journal of Experimental & Clinical Cancer Research;2024-03-09
2. Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast;Cancers;2023-03-18
3. Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer;Translational Breast Cancer Research;2023-01
4. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation;Phytomedicine;2022-07
5. Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies;Clinical Breast Cancer;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3